Disc Medicine Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Disc Medicine stock have an average target of 72, with a low estimate of 40 and a high estimate of 118. The average target predicts an increase of 12.54% from the current stock price of 63.98.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$40	$72	$73	$118
Change	-37.48%	+12.54%	+14.10%	+84.43%

Analyst Ratings

The average analyst rating for Disc Medicine stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	2	2	2	2	3	3
Buy	3	3	5	5	6	6
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	8	8	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $70 → $118	Strong Buy	Maintains	$70 → $118	+84.43%	Nov 13, 2024
Greg Harrison Scotiabank	Scotiabank	Buy Maintains $62 → $70	Buy	Maintains	$62 → $70	+9.41%	Nov 5, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $70	Strong Buy	Reiterates	$70	+9.41%	Nov 5, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $70	Strong Buy	Reiterates	$70	+9.41%	Oct 28, 2024
Roger Song Jefferies	Jefferies	Strong Buy Initiates $89	Strong Buy	Initiates	$89	+39.11%	Oct 23, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-4.20

from -3.42

EPS Next Year

-5.19

from -4.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	19.28M	27.91M
Revenue Growth	-	-	-	-	-	-	-	44.75%
EPS	-3.02	-40.95	-45.05	-3.42	-4.20	-5.19	-5.54	-6.86
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	14	13	12	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	n/a	57.1M
Avg	n/a	n/a	19.3M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-4.07	-4.31	-3.18
Avg	-4.20	-5.19	-5.54
Low	-4.37	-6.04	-8.05

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.